Packaging Pharmaceutical Companies White Paper 
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical companies need to be prepared to answer the call for increased demand and supply into new markets, ensuring the proper resources and logistics framework are in place. While using high-capacity aircraft and minimal packaging reduces weight and increases capacity for vital products by using fewer flights.
Pharmaceutical Technology
JUNE 6, 2025
In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
JUNE 19, 2025
Large pharmaceutical companies such as AbbVie, Lilly, Roche and Takeda have demonstrated strong interest in licensing innovator oligonucleotides for CNS indications, accounting for 63% of licensing deals between 2021 and 2025 year-to-date. ASOs accounted for more than half ($3.54 billion), while siRNAs made up more than a third ($2.51
Pharmaceutical Technology
FEBRUARY 9, 2023
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceutical manufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
European Pharmaceutical Review
DECEMBER 21, 2022
All traditional small molecule pharmaceuticals include carbon building blocks – by definition, organic materials – which are then transformed via modern synthetic chemistry to assemble the complex and highly variable skeletons that the final target structures demand. European Federation of Pharmaceutical Industries and Associations.
Pharmaceutical Technology
FEBRUARY 3, 2023
Compared to other dosage forms, tablets are simpler to manufacture, package, and transport. As with any pharmaceutical manufacturing, challenges can be many, and processes are highly regulated.
Pharmaceutical Technology
FEBRUARY 7, 2023
They can also give their feedback on the design of the clinical trial, if the comparator reflects the standard of care, and if real-world evidence is part of the evidence requirement package.” Overall, it is never too soon to begin market access activities, but it can easily be too late.
Expert insights. Personalized for you.
142 
Let's personalize your content